In contrast, IL-2 treatment attenuated and even reversed depression- and anxiety-like behaviors by normalizing the deficiency of monoamine neurotransmitters and the increase in neurotransmitter metabolism in the hippocampus and amygdala. Here, IL2 is linked to major depressive disorder.